News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
394,350 Results
Type
Article (26353)
Company Profile (60)
Press Release (367935)
Multimedia
Podcasts (35)
Webinars (7)
Section
Business (104378)
Career Advice (456)
Deals (16887)
Drug Delivery (53)
Drug Development (47735)
Employer Resources (47)
FDA (12353)
Job Trends (8486)
News (186351)
Policy (19527)
Tag
2027 Biotech Bay Standard (1)
2027 Pharm Country Standard (1)
Academia (1759)
Accelerated approval (14)
Adcomms (10)
Allergies (115)
Alliances (26824)
ALS (98)
Alzheimer's disease (980)
Antibody-drug conjugate (ADC) (167)
Approvals (12692)
Artificial intelligence (317)
Autoimmune disease (99)
Automation (8)
Bankruptcy (142)
Best Places to Work (6891)
BIOSECURE Act (5)
Biosimilars (74)
Biotechnology (40)
Bladder cancer (127)
Brain cancer (38)
Breast cancer (425)
Cancer (3141)
Cardiovascular disease (269)
Career advice (417)
Career pathing (16)
CAR-T (136)
CDC (28)
Celiac Disease (2)
Cell therapy (370)
Cervical cancer (26)
Clinical research (43022)
Collaboration (877)
Compensation (277)
Complete response letters (16)
COVID-19 (1555)
CRISPR (38)
C-suite (520)
Cystic fibrosis (59)
Data (4328)
Decentralized trials (2)
Denatured (21)
Depression (97)
Diabetes (320)
Diagnostics (3737)
Digital health (32)
Diversity (7)
Diversity, equity & inclusion (13)
Drug discovery (98)
Drug pricing (91)
Drug shortages (22)
Duchenne muscular dystrophy (126)
Earnings (38705)
Editorial (30)
Employer branding (6)
Employer resources (47)
Events (54276)
Executive appointments (600)
FDA (14677)
Fibrodysplasia Ossificans Progressiva (2)
Friedreich's ataxia (6)
Frontotemporal dementia (10)
Funding (772)
Gene editing (78)
Generative AI (22)
Gene therapy (264)
GLP-1 (545)
Government (3147)
Grass and pollen (4)
Guidances (230)
Healthcare (12215)
HIV (42)
Huntington's disease (21)
IgA nephropathy (51)
Immunology and inflammation (87)
Immuno-oncology (29)
Indications (78)
Infectious disease (1697)
Inflammatory bowel disease (118)
Inflation Reduction Act (7)
Influenza (56)
Intellectual property (122)
Interviews (40)
IPO (7072)
IRA (23)
Job creations (1846)
Job search strategy (382)
JPM (19)
Kidney cancer (11)
Labor market (37)
Layoffs (196)
Leadership (9)
Legal (3647)
Liver cancer (66)
Longevity (7)
Lung cancer (500)
Lymphoma (257)
Machine learning (16)
Management (17)
Manufacturing (296)
MASH (108)
Medical device (13322)
Medtech (13371)
Mergers & acquisitions (10331)
Metabolic disorders (766)
Multiple sclerosis (102)
NASH (11)
Neurodegenerative disease (167)
Neuropsychiatric disorders (43)
Neuroscience (1718)
NextGen: Class of 2026 (3933)
Non-profit (2840)
Now hiring (35)
Obesity (318)
Opinion (99)
Ovarian cancer (120)
Pain (142)
Pancreatic cancer (146)
Parkinson's disease (166)
Partnered (17)
Patents (233)
Patient recruitment (371)
Peanut (43)
People (35715)
Pharmaceutical (15)
Pharmacy benefit managers (16)
Phase 1 (12358)
Phase 2 (18609)
Phase 3 (15287)
Pipeline (3259)
Policy (130)
Postmarket research (1668)
Preclinical (3804)
Press Release (18)
Prostate cancer (181)
Psychedelics (27)
Radiopharmaceuticals (182)
Rare diseases (442)
Real estate (2869)
Recruiting (19)
Regulatory (15763)
Reports (19)
Research institute (1660)
Resumes & cover letters (50)
Rett syndrome (16)
RNA editing (5)
RSV (43)
Schizophrenia (115)
Series A (117)
Series B (95)
Service/supplier (2)
Sickle cell disease (47)
Special edition (7)
Spinal muscular atrophy (104)
Sponsored (17)
Startups (2134)
Stomach cancer (11)
Supply chain (60)
Tariffs (25)
The Weekly (14)
Vaccines (514)
Venture capital (28)
Weight loss (212)
Women's health (59)
Worklife (4)
Date
Today (28)
Last 7 days (277)
Last 30 days (1219)
Last 365 days (16087)
2026 (2076)
2025 (16467)
2024 (19845)
2023 (22735)
2022 (30681)
2021 (32984)
2020 (32190)
2019 (28413)
2018 (21810)
2017 (18906)
2016 (18111)
2015 (21194)
2014 (16023)
2013 (13241)
2012 (14349)
2011 (14622)
2010 (13181)
Location
Africa (367)
Alabama (31)
Alaska (2)
Arizona (178)
Arkansas (10)
Asia (25523)
Australia (4035)
California (5663)
Canada (1941)
China (798)
Colorado (288)
Connecticut (294)
Delaware (254)
Europe (49995)
Florida (967)
Georgia (230)
Hawaii (1)
Idaho (35)
Illinois (591)
India (34)
Indiana (386)
Iowa (11)
Japan (327)
Kansas (92)
Kentucky (20)
Louisiana (18)
Maine (28)
Maryland (904)
Massachusetts (3808)
Michigan (156)
Minnesota (450)
Mississippi (5)
Missouri (80)
Montana (19)
Nebraska (21)
Nevada (65)
New Hampshire (74)
New Jersey (1959)
New Mexico (10)
New York (1594)
North Carolina (829)
North Dakota (4)
Northern California (2696)
Ohio (216)
Oklahoma (8)
Oregon (28)
Pennsylvania (1378)
Puerto Rico (12)
Rhode Island (35)
South America (523)
South Carolina (61)
Southern California (2277)
Tennessee (128)
Texas (1034)
United States (22013)
Utah (198)
Virginia (145)
Washington D.C. (52)
Washington State (389)
West Virginia (4)
Wisconsin (73)
Wyoming (1)
394,350 Results for "qview medical".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Medical-imaging company Imagion Biosystems Lodges IND with FDA for Phase 2 Trial of MagSense® HER2 targeted imaging agent
February 4, 2026
·
2 min read
Press Releases
Envoy Medical Provides Business Update Following Transformative Financing and Positive Progress in Clinical Trial
Financing was led by new investor and top-tier healthcare fund Nantahala Capital and longtime Envoy Medical shareholder, billionaire Glen Taylor Closing of $30 million in gross proceeds in upsized offering, with up to an additional $48 Million upon exercise of milestone warrants, provides potential funding through commercialization Company hosting Fireside Chat with Dr. Theodore McRackan, on February 25th at 10 a.m. ET, to discuss his initial experiences as clinical trial’s leading implanter
February 19, 2026
·
10 min read
Press Releases
Intricon becomes Forj Medical and Announces Opening Plans for its Advanced Manufacturing Facility in Costa Rica
Intricon completes construction of its Evolution Free Zone location, combines with Minnetronix Medical, and will fly the Forj Medical flag at its new site; equipment and workforce move into place for the grand opening
December 9, 2025
·
1 min read
Press Releases
Turn Therapeutics Enters Global Supply, Development, and License Agreement with Leading Medical-Surgical Product Manufacturer and Distributor Medline
October 31, 2025
·
3 min read
Press Releases
Microbot Medical®’s LIBERTY® Endovascular Robotic System Highlighted at a Leading Vascular Disease Management Conference
February 12, 2026
·
5 min read
Press Releases
Tenon Medical(R) Announces FDA 510(k) Clearance for SImmetry(R)+ SI Joint Fusion System
October 22, 2025
·
4 min read
Press Releases
Seno Medical’s Next-Generation Imagio® Imaging System Obtains European Union (EU) Medical Device Regulation (MDR) CE Mark Certification
January 29, 2026
·
3 min read
Earnings
AstraZeneca Builds Obesity Pipeline On ‘Medical Aspect,’ Not Aesthetics
In an investor call Thursday, AstraZeneca CEO Pascal Soriot outlined his company’s approach to obesity drug development based on “the medical aspect” of weight loss, including driving down visceral fat.
November 6, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Microbot Medical®’s LIBERTY® Endovascular Robotic System Continues to Expand Market Visibility; Being Featured at an Industry Leading Innovation Conference
February 19, 2026
·
4 min read
Press Releases
AVITA Medical Reports Fourth Quarter and Full Year 2025 Financial Results
February 12, 2026
·
14 min read
1 of 39,435
Next
